CA3308038A1 - Compositions pour traiter le cancer - Google Patents

Compositions pour traiter le cancer

Info

Publication number
CA3308038A1
CA3308038A1 CA3308038A CA3308038A CA3308038A1 CA 3308038 A1 CA3308038 A1 CA 3308038A1 CA 3308038 A CA3308038 A CA 3308038A CA 3308038 A CA3308038 A CA 3308038A CA 3308038 A1 CA3308038 A1 CA 3308038A1
Authority
CA
Canada
Prior art keywords
cancer
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3308038A
Other languages
English (en)
Inventor
Dimiter S. Dimitrov
M. Mounzer E. AGHA
Original Assignee
Gencart Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gencart Inc filed Critical Gencart Inc
Publication of CA3308038A1 publication Critical patent/CA3308038A1/fr
Pending legal-status Critical Current

Links

CA3308038A 2023-10-13 2024-10-14 Compositions pour traiter le cancer Pending CA3308038A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/543,994 2023-10-13

Publications (1)

Publication Number Publication Date
CA3308038A1 true CA3308038A1 (fr) 2025-04-17

Family

ID=

Similar Documents

Publication Publication Date Title
AU2024220916A1 (en) Tricyclic compounds for the treatment of cancer
EP3781564A4 (fr) Composés pour le traitement d'un cancer
EP4319741A4 (fr) Compositions et procédés pour le traitement du cancer
AU2024353718A1 (en) Compositions for treating cancer
EP4031130A4 (fr) Compositions pour le traitement de tumeurs solides
EP4051260A4 (fr) Méthodes et compositions de traitement du cancer
CA3308038A1 (fr) Compositions pour traiter le cancer
AU2021372815A9 (en) Combination treatment of cancer
AU2022231043A1 (en) Chaperonin-containing tcp-1 inhibitors for the treatment of cancer
HK40114028A (en) Compounds and compositions thereof for the treatment of cancer
AU2021903792A0 (en) Compounds and compositions thereof for the treatment of cancer
CA3285811A1 (fr) Compositions et méthodes pour le traitement du cancer
HK40114414A (en) Dr5-targeting multabodies for the treatment of cancer
CA3305948A1 (fr) Compositions pour le traitement du cancer
HK40094743A (en) Combinations for the treatment of cancer
HK40117352A (en) Methods and compositions for the treatment of cancer
AU2023901809A0 (en) Compositions for the treatment and prevention of cancer
HK40128051A (en) Compositions for the treatment of disease
AU2022902823A0 (en) Compositions for the treatment and prevention of cancer
CA3284076A1 (fr) Agents thérapeutiques dirigés contre l'os pour le traitement du cancer
AU2020902478A0 (en) Compositions and methods for the treatment of cancer
AU2021904265A0 (en) Compositions for the treatment and prevention of cancer
CA3263777A1 (fr) Dysosmobacter pour le traitement du cancer du sein
HK40112300A (en) Methods for the treatment of cancer
AU2021900290A0 (en) Compositions for the treatment and prevention of cancer